GB2144408A - Imidazole derivatives - Google Patents

Imidazole derivatives Download PDF

Info

Publication number
GB2144408A
GB2144408A GB08321000A GB8321000A GB2144408A GB 2144408 A GB2144408 A GB 2144408A GB 08321000 A GB08321000 A GB 08321000A GB 8321000 A GB8321000 A GB 8321000A GB 2144408 A GB2144408 A GB 2144408A
Authority
GB
United Kingdom
Prior art keywords
phenyl
thienyl
chlorophenyl
yield
treated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB08321000A
Other languages
English (en)
Other versions
GB8321000D0 (en
Inventor
Kazuo Matsumoto
Yoshio Iwasawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Priority to GB08321000A priority Critical patent/GB2144408A/en
Publication of GB8321000D0 publication Critical patent/GB8321000D0/en
Priority to JP59146678A priority patent/JPS6034951A/ja
Publication of GB2144408A publication Critical patent/GB2144408A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB08321000A 1983-08-04 1983-08-04 Imidazole derivatives Withdrawn GB2144408A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB08321000A GB2144408A (en) 1983-08-04 1983-08-04 Imidazole derivatives
JP59146678A JPS6034951A (ja) 1983-08-04 1984-07-13 イミダゾール誘導体及びその製法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08321000A GB2144408A (en) 1983-08-04 1983-08-04 Imidazole derivatives

Publications (2)

Publication Number Publication Date
GB8321000D0 GB8321000D0 (en) 1983-09-07
GB2144408A true GB2144408A (en) 1985-03-06

Family

ID=10546784

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08321000A Withdrawn GB2144408A (en) 1983-08-04 1983-08-04 Imidazole derivatives

Country Status (2)

Country Link
JP (1) JPS6034951A (enrdf_load_stackoverflow)
GB (1) GB2144408A (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017390A1 (de) * 1993-12-21 1995-06-29 Bayer Aktiengesellschaft N-substituierte aryl-trifluormethylimidazole

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995033730A1 (fr) * 1994-06-09 1995-12-14 Nippon Soda Co., Ltd. Derive d'imidazole, procede de production et herbicide
JP5858884B2 (ja) * 2012-08-16 2016-02-10 四国化成工業株式会社 チオフェン環を有するイミダゾール化合物
KR102253652B1 (ko) * 2019-08-19 2021-05-18 주식회사 셀젠텍 신규한 암전이 억제 활성을 갖는 화합물, 이의 제조방법 및 상기 화합물을 포함하는 암 전이 및 침윤 억제, 또는 암 치료용 약학적 조성물

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017390A1 (de) * 1993-12-21 1995-06-29 Bayer Aktiengesellschaft N-substituierte aryl-trifluormethylimidazole

Also Published As

Publication number Publication date
GB8321000D0 (en) 1983-09-07
JPS6034951A (ja) 1985-02-22
JPH0544456B2 (enrdf_load_stackoverflow) 1993-07-06

Similar Documents

Publication Publication Date Title
US4569942A (en) N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
RU2021990C1 (ru) Способ получения производных пиразола или их фармацевтически приемлемых солей
AU778819B2 (en) 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
US6054590A (en) Imidazolone anorectic agents: II. phenyl derivatives
KR101754940B1 (ko) 3-치환된 1ｈ-피롤 및 방향족 및 헤테로 방향족 스페이서에 동시에 기반한 신규한 히스톤 디아세틸라아제 저해제
US4882342A (en) 5-alkylbenzimidazoles, method of use and pharmaceutical compositions
IE57743B1 (en) 3-substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
WO1989003818A1 (en) Novel fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
CZ20032829A3 (cs) Heterocyklické sloučeniny
KR20110071004A (ko) 페네틸아미드 유도체 및 이의 헤테로시클릭 유사체
JPWO2010035727A1 (ja) 新規ピロリノン誘導体およびそれを含有する医薬組成物
AU750019B2 (en) Aryl alkanoylpyridazines
US4721712A (en) 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
AU2005284248A1 (en) Indole derivatives as antiviral agents
JP2010507664A (ja) ベンズイミダゾール化合物
CN103058949A (zh) 做为dhodh抑制剂的噻唑衍生物及其应用
US4658037A (en) Intermediates for 1,3-disubstituted 2-oxindoles as analgesic and antiinflammatory agents
JPH07107056B2 (ja) ４（３ｈ）−キナゾリノン誘導体、その製造方法およびそれを有効成分とする抗潰瘍剤
US4398028A (en) Bicyclic heterocyclic amino derivatives
GB2144408A (en) Imidazole derivatives
HU184851B (en) Process for producing 4,5-diaryl-alpha-bracket-polyfluoro-alkyl-bracket closed-ih-pyrrol-2-methan-amines and antiphlogistic pharmaceutical kompositions containing them
EP0005156B1 (en) 4,5-diaryl-2-(substituted-thio)-pyrroles and their corresponding sulfoxides and sulfones, process for their preparation and pharmaceutical compositions containing them
HUT52038A (en) Process for producing alpha-cyano-beta-oxo-propion-amides
EP0259085A1 (en) 2-Guanidino-4-arylthiazoles for treatment of peptic ulcers
JPH0327363A (ja) チオウラシル誘導体

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)